Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Griffiths

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Mechanisms of Ageing and Development|October 1, 1973
A new unifying theory for the initiation of ageing mechanisms and processesT R Griffiths
Journal of the Royal Society of Medicine|March 13, 1998
Localized prostate cancer: early intervention or expectant therapy?T R Griffiths, D E Neal
BJU International|October 6, 1999
Human papillomavirus and urological tumours: I. Basic science and role in penile cancerT R Griffiths, J K Mellon
BJU International|February 15, 2000
Human papillomavirus and urological tumours: II. Role in bladder, prostate, renal and testicular cancerT R Griffiths, J K Mellon
Postgraduate Medical Journal|December 1, 1996
Bladder cancerH Y Leung, T R Griffiths, D E Neal
Clinical and Experimental Immunology|December 12, 2001
Distribution of lymphocytes of the alpha(E)beta(7) phenotype and E-cadherin in normal human urothelium and bladder carcinomasJ Cresswell, H Robertson, D E Neal, et al.
British Journal of Urology|November 1, 1995
P53 and ploidy assessed by flow cytometry in bladder washingsT R Griffiths, J K Mellon, G A Pyle, et al.
British Journal of Cancer|July 2, 1998
Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: high frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosisR Abdel-Fattah, C Challen, T R Griffiths, et al.
Clinical and Experimental Immunology|April 21, 1999
Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4+ T cell activation in vitroS J Pettit, S Ali, E O'Flaherty, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2001
Combined p21WAF1/CIP1 and p53 overexpression predict improved survival in muscle-invasive bladder cancer treated by radical radiotherapyK N Qureshi, T R Griffiths, M C Robinson, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Mechanisms of Ageing and Development|October 1, 1973
A new unifying theory for the initiation of ageing mechanisms and processesT R Griffiths
Journal of the Royal Society of Medicine|March 13, 1998
Localized prostate cancer: early intervention or expectant therapy?T R Griffiths, D E Neal
BJU International|October 6, 1999
Human papillomavirus and urological tumours: I. Basic science and role in penile cancerT R Griffiths, J K Mellon
BJU International|February 15, 2000
Human papillomavirus and urological tumours: II. Role in bladder, prostate, renal and testicular cancerT R Griffiths, J K Mellon
Postgraduate Medical Journal|December 1, 1996
Bladder cancerH Y Leung, T R Griffiths, D E Neal
Clinical and Experimental Immunology|December 12, 2001
Distribution of lymphocytes of the alpha(E)beta(7) phenotype and E-cadherin in normal human urothelium and bladder carcinomasJ Cresswell, H Robertson, D E Neal, et al.
British Journal of Urology|November 1, 1995
P53 and ploidy assessed by flow cytometry in bladder washingsT R Griffiths, J K Mellon, G A Pyle, et al.
British Journal of Cancer|July 2, 1998
Alterations of TP53 in microdissected transitional cell carcinoma of the human urinary bladder: high frequency of TP53 accumulation in the absence of detected mutations is associated with poor prognosisR Abdel-Fattah, C Challen, T R Griffiths, et al.
Clinical and Experimental Immunology|April 21, 1999
Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4+ T cell activation in vitroS J Pettit, S Ali, E O'Flaherty, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2001
Combined p21WAF1/CIP1 and p53 overexpression predict improved survival in muscle-invasive bladder cancer treated by radical radiotherapyK N Qureshi, T R Griffiths, M C Robinson, et al.
Pageof 2